ATE111957T1 - Transformiertes shigella. - Google Patents

Transformiertes shigella.

Info

Publication number
ATE111957T1
ATE111957T1 AT90400326T AT90400326T ATE111957T1 AT E111957 T1 ATE111957 T1 AT E111957T1 AT 90400326 T AT90400326 T AT 90400326T AT 90400326 T AT90400326 T AT 90400326T AT E111957 T1 ATE111957 T1 AT E111957T1
Authority
AT
Austria
Prior art keywords
strain
wild strain
shigella
invasive
wild
Prior art date
Application number
AT90400326T
Other languages
English (en)
Inventor
Philippe Sansonetti
Maria Lina Bernardini
Annick Fontaine
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE111957T1 publication Critical patent/ATE111957T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90400326T 1990-02-06 1990-02-06 Transformiertes shigella. ATE111957T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400326A EP0441071B1 (de) 1990-02-06 1990-02-06 Transformiertes Shigella

Publications (1)

Publication Number Publication Date
ATE111957T1 true ATE111957T1 (de) 1994-10-15

Family

ID=8205683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400326T ATE111957T1 (de) 1990-02-06 1990-02-06 Transformiertes shigella.

Country Status (6)

Country Link
EP (1) EP0441071B1 (de)
JP (1) JPH04505399A (de)
AT (1) ATE111957T1 (de)
CA (1) CA2051434A1 (de)
DE (1) DE69012784D1 (de)
WO (1) WO1991012321A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877159A (en) * 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US6150170A (en) * 1998-05-03 2000-11-21 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US6682729B1 (en) 1995-05-03 2004-01-27 University Of Maryland, Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
WO1997014810A1 (en) * 1995-10-18 1997-04-24 Pharmacia & Upjohn Company Use of procaryotic hosts for expression of gene in eucaryotic cells
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
CN101720229A (zh) * 2007-04-25 2010-06-02 以沃尔特里德军事研究所的名义,由美国陆军部部长为代表的美国政府 活减毒志贺氏菌疫苗株基因缺失组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR242989A1 (es) * 1988-07-15 1993-06-30 Inst Pasteur I Nat De La Sante Metodo para modificar una cepa salvaje de una shigella entero-invasora para producir una cepa modificada apta para preparar una vacuna contra la cepa salvaje y cepa de shigella asi modificada.

Also Published As

Publication number Publication date
EP0441071A1 (de) 1991-08-14
WO1991012321A1 (en) 1991-08-22
EP0441071B1 (de) 1994-09-21
CA2051434A1 (en) 1991-08-07
JPH04505399A (ja) 1992-09-24
DE69012784D1 (de) 1994-10-27

Similar Documents

Publication Publication Date Title
ES2054708T3 (es) Gen de resistencia frente a fosfinotricina, activo en plantas y su utilizacion.
ATE127694T1 (de) Lebende impfstoffe.
KR900700603A (ko) 리보자임
Mandl et al. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen
NO973059L (no) Hydroksylaminderivater som er anvendbare for å öke den molekylære chaperonproduksjon, og fremstilling derav
DE68929343D1 (de) Modifizierte Zellen mit Resistenz gegen Retroviralinfektionen
DE69129897D1 (de) Methode des gentransfers mittels retrotransposons
BR9712138A (pt) Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
ATE138384T1 (de) Olionukleotidalkylphosphonate und - phosphonothioate
DK0724642T4 (da) Nucleinsyrevektor, sammensætning indeholdende en sådan vektor og vaccine til immunisering mod hepatitis
GR880100421A (el) Γονιδιο που αποικοδομει αλοαρυλνιτριλιο,η χρηση του και κυτταρα που περιεχουν το γονιδιο.
DK1214440T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
ATE111957T1 (de) Transformiertes shigella.
DE69232231D1 (de) Manipulierung der Anzahl von Gen-Kopien bei Bordetella
ES2074280T3 (es) Metodo para modificar el tropismo de celula, tejido o huesped de un microorganismo, microorganismos recombinantes obtenidos de este modo y su uso en medicina y medicina veterinaria.
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
NO892029L (no) Fremgangsmaate ved spesifikk genetisk manipulering av mikroorganisme.
ES2148164T3 (es) Cepa atenuada de vacuna del virus del sarampion, que contiene una secuencia nucleotidica especifica y procedimiento para su identificacion.
ATE310747T1 (de) Impfstoff gegen geflügelkokzidose
Budowsky et al. Principles of selective inactivation of viral genome. V. Rational selection of conditions for inactivation of the viral suspension infectivity to a given extent by the action of β-propiolactone
DE69629819D1 (de) Avirulente herpetische viren verwendbar als tumorzerstörendes agens und impfstoff
KR900702025A (ko) 형질 변환된 시겔라(Shigella)
ATE66690T1 (de) Unikale, monogenetische streptokinase, ihre herstellung und verwendung.
SE8205247L (sv) Fiskvacciner
Dhillon et al. Photodynamic therapy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties